Toxic epidermal necrolysis induced by exposure to S,S-dimethyl cyanoimidodithiocarbonate: case report and nursing experience
By
Xue-Qing Liu
Xiao-Lan Dong
Yue-Tong Qian
Chang Shu
May 28, 2026
Clinical Scorecard: Toxic Epidermal Necrolysis Triggered by S,S-Dimethyl Cyanoimidodithiocarbonate: A Case Study and Nursing Insights
At a Glance
Category Detail
Condition Key Mechanisms Severe skin and mucosal reaction characterized by blistering and epidermal detachment, often drug-induced. Target Population Care Setting
Key Highlights
Patient presented with >60% body surface area involvement. Key treatments included systemic glucocorticoids, cyclosporine, intravenous immunoglobulin, and infliximab. Guideline-Based Recommendations
Diagnosis
Diagnosis based on clinical presentation and history of exposure to triggering agents. Management
Use of systemic glucocorticoids, cyclosporine, intravenous immunoglobulin, and infliximab. Monitoring & Follow-up
Regular assessment of skin integrity and signs of infection. Risks
High risk of infection and potential for multiorgan failure. Patient & Prescribing Data
Patients with TEN, particularly those with significant epidermal detachment.
Clinical Best Practices
Implement strict aseptic techniques during wound care. Maintain a controlled environment to enhance patient comfort during procedures. Related Resources & Content
